Federal authorities say wholesale drug distributor McKesson Corp. will pay more than $190 million to settle claims that it led Medicaid to overpay for drugs by reporting inflated prices to a publisher.
New Jersey U.S. Attorney Paul Fishman and other officials said Thursday that McKesson marked up the average drug prices it reported to publisher First DataBank by 25 percent between 2001 and 2005.
Most state Medicaid programs use First DataBank information to determine what they pay for drugs.
Authorities say Medicaid ended up paying too much for a variety of brand-name pharmaceuticals that McKesson sells. They said the alleged scheme violated the False Claims Act.
In a statement, McKesson denied manipulating drug prices or violating any law. It said it settled to avoid the costs and uncertainty of litigation.
Wyo., ND Governors To EPA: Hey, We Need More Time On Clean Power Plan Because You Totally ‘Blindsided’ Us | Matt Vespa
Watch Mika Brzezinski explain how AR 15s can “blow up animals”
'Daily Show' host Trevor Noah wishes 'pro-lifers' would devote their zeal to gun control - twitchy.com
Oregon Town Blasts Obama's "Inappropriate," "Disrespectful" Visit After College Shooting - Bearing Arms - Barack Obama, Mass shootings, Umpqua Community College
The Russian infringement of Turkish airspace is bigger than it seems | RedState
Thomas Sowell - Charlatans and Sheep
Crony Capitalism Driving Nevada Energy Controversy | Human Events
The New Norm?